To investigate whether endothelial dysfunction assessed by brachial artery flow-mediated dilation (FMD) is associated with urinary albumin excretion (UAE) and is interrelated with carotid intima-media thickness (IMT) and pulse-wave velocity (PWV) in type 2 diabetes. 
Introduction
Vascular endothelium impairment is a key initial step in atherogenesis 1) . The vasodilator response to increased conduit arterial flow (flow-mediated dilation, FMD) is dependent on local nitric oxide bioavailability, and measurement of this response has been widely used in clinical studies 2) . FMD of the brachial artery during reactive hyperemia caused by endothelium-dependent vasodilation is measured with an ultrasound technique 2, 3) . FMD may be affected by vascular stiffness and thickness. Vascular wall measurements of FMD, stiffness and thickness are likely affected by hyperglycemia 1) . The relationship of FMD with vascular stiffness and thickness would be important for elucidation of the pathophysiology of premature atherosclerosis, particularly in diabetes.
Study of preclinical atherosclerosis has already been facilitated by use of non-invasive ultrasound and oscillometric techniques. Early changes in atheroscle-rosis are detected by measuring the intima-media thickness (IMT) of the carotid artery 4, 5) and pulse wave velocity (PWV) conducting over large and middle arteries [6] [7] [8] [9] [10] . IMT and PWV measurements are considered to exhibit arterial thickness and stiffness. IMT and PWV, which are closely related with a correlation coefficient being around 0.35, are likely to measure early changes of atherosclerosis from structural and functional points of view, respectively 6, 8, 9) . Introduction of these measures to an individual would help to predict cardiovascular events in non-diabetic and diabetic populations 5, 7, 10) . These markers of vascular wall properties are currently used as surrogate outcomes of vascular events in intervention studies of individuals with diabetes 11) . Vascular wall properties in association with the urinary albumin excretion rate (UAE) are of great interest, since elevated UAE is associated with an increased risk of cardiovascular disease (CVD) among individuals with and without type 2 diabetes [12] [13] [14] . While the pathophysiological mechanism linking elevated UAE to CVD is unknown, the most commonly held view is that elevated UAE reflects a pathophysiological process predisposing an individual to atherosclerosis 12) . Diabetes is a well-known risk factor for vascular events, but the association of slightly elevated UAE, i.e., microalbuminuria, with endothelial dysfunction as evaluated by FMD of the brachial artery has not yet been fully studied. Associations of microalbuminuria with IMT and PWV have been found 8, [15] [16] [17] ; therefore, the hypothesis tested was that endothelial function assessed by FMD is impaired in subjects with type 2 diabetes and microalbuminuria, and that this is interrelated with IMT and PWV.
Methods

Study population
A total of 158 subjects with type 2 diabetes were recruited from the outpatient clinic at Jiyugaoka Internal Medicine in consecutive fashion. Subjects were allocated according to the urinary albumin to creatinine ratio (ACR; mg/gcr). The ACR was measured three times and normoalbuminuria, microalbuminuria, and macroalbuminuria were defined as an ACR 30 mg/gcr, ACR 30 and 300 mg/gcr, and ACR 300 mg/gcr, respectively, in at least two of three consecutive samples. The goal was to obtain three groups which included more than 45 subjects in each group, so that 45 subjects in one group multiplied by 3 groups was 135 subjects, considered minimal to investigate the explanatory variables of FMD in multiple regression analysis. Subjects were recruited consecutively during a certain period until the number met the criteria. Subjects with impaired hepatic/cardiac function, or uncontrolled hypertension were excluded. Subjects had been under treatment for blood glucose, blood pressure, and lipid profile control through their regular visits for a year or more according to the guidelines of the Japan Diabetes Society 18) , and the medication was unchanged for three months or more prior to the study examination. The study was carried out in accordance with the Helsinki Declaration and approved by the ethics committee, with written informed consent given by all participants.
Type 2 diabetes was diagnosed according to the Japan Diabetes Society criteria 18) . Hypertension was defined by systolic blood pressure (SBP) more than 140 mmHg or diastolic blood pressure (DBP) above 90 mmHg, or both, or patients already being treated with antihypertensive drugs. Dyslipidemia was defined as serum concentrations of total cholesterol 5.7 mmol/L, triglycerides (TG) 1.7 mmol/L, or high density lipoprotein cholesterol (HDL) 1.0 mmol/L, or patients already being treated by lipid-lowering agents. Low density lipoprotein cholesterol (LDL) was calculated by Friedewald's formula. Diabetic retinopathy was diagnosed after pupillary dilation by ophthalmologists and graded as no retinopathy, simple retinopathy or proliferative retinopathy by ophthalmologists. Neuropathy was diagnosed in patients with two or more of the following three components: presence of symptoms, absence of ankle tendon reflexes, or abnormal scores of vibration perception threshold using a C128 tuning fork, where bilateral spontaneous pain, hypoesthesia, or paresthesia of the legs was considered to be a neuropathic symptom. Smoking was defined as never/past/current.
Risk factor measurement
Blood pressure was measured with an appropriately sized cuff in the sitting position after resting for more than 15 minutes. Fasting blood samples were obtained for measurements of glycosylated hemoglobin A1C (A1C), plasma concentrations of glucose, and serum concentrations of creatinine and lipids. HbA1C was measured by high-performance liquid chromatography (ADAMS TM A1c HA8160; Arkray, Kyoto, Japan; normal range 4.3-5.8%), which was standardized by the Japan Diabetes Society and was calibrated every 2 weeks using GlycoHB (Kokusai Shiyaku, Kobe, Japan) as a control, and was certified by the American National Glycohemoglobin Standardization Program (NGSP 1.019 JDS 0.30). Serum and urinary concentrations of creatinine were measured by an enzymatic method. Urinary albumin was measured by a turbidimetric immunoassay. UAE was measured using the ACR in random urine samples, and the geometric mean of the three samples was used as a continuous variable of UAE. The glomerular filtration rate (GFR) was estimated using the following equation qualified by The Japanese Society of Nephrology: eGFR (ml/min/1.73m 2 ) 194 Scr 1.094 Age 0.287 0.739 (if female) 19) .
Measurement of FMD
Subjects visited the clinic after an overnight fast, without smoking, drinking coffee, or taking antioxidant vitamins for at least 12 h prior to testing. Subjects were examined in the supine position after 15 minutes of rest in a dark, quiet, air-conditioned room (22) (23) (24) . Brachial artery FMD was measured by a trained technician according to the guidelines for the ultrasound assessment 20) . A linear-array transducer operating at 10 MHz was used to acquire longitudinal images of the right brachial artery. A standard blood pressure cuff was positioned around the right arm, 5 cm below the antecubital fossa, and the artery was imaged 5 to 9 cm above the antecubital fossa. After baseline images were obtained, the cuff was inflated to 50 mmHg above SBP for 5 minutes. The diastolic prebeat diameter of the brachial artery was determined semi-automatically using an instrument equipped with software for monitoring the brachial artery diameter (Unex Co. Ltd., Nagoya, Japan), and the validity and reproducibility of this equipment were confirmed elsewhere 3) . Digitized images of the right brachial artery were captured continuously for 30 seconds before cuff inflation and for 2 minutes beginning immediately before cuff deflation to document the vasodilator response. FMD was calculated as the percentage change in diameter from the baseline value before cuff release to the peak value after cuff release. The reproducibility of the FMD measurement was assessed on three different days in 15 subjects. Ultrasound studies and image analysis were separately performed by independent investigators in an observer-blinded fashion. The coefficient of variation was 3.1% for baseline diameter measurement, and 11.4% for %FMD measurement.
Measurement of IMT and PWV
Carotid IMT was measured using the Shimadzu SDU-2200 (Shimadzu Co., Ltd, Kyoto, Japan) at a transducer frequency of 5-10 MHz. Computer-assisted acquisition, processing, storage of B-mode images, and calculation of IMT were performed with the software Intima Scope (Media Cross Co. Ltd, Tokyo, Japan). Details of the method and its validity and reproducibility have been described previously 8) . Briefly, two measurements on longitudinal views of both right and left common carotid arteries were made at the far wall of a 20-mm segment distal to the carotid bulbs. For each measurement, the average and maximum values were calculated automatically. Only the average IMT was used in this study as the average and maximal values correlated significantly (r 0.94, P 0.0001). The average value of IMT was obtained by computerized calculation of the area detected, and the greatest value was used as the representative of each individual. The mean intra-observer and interobserver coefficients of variation were 4.8 and 3.0% 8) . Brachial-ankle PWV was measured using a volumeplethysmographic apparatus (form PWV/ABI version 112; Colin Co. Ltd, Komaki, Japan). Details of the method have been described previously 8, 16) . The interobserver and intra-observer variation coefficients were 8.4 and 10.0%, respectively.
Statistical analysis
Results are given as the mean SD unless otherwise stated. The significance of differences between the groups was determined by chi-squared tests for categorical variables and the unpaired Student's t-test for continuous variables. For comparisons of FMD, IMT, and PWV in normo-, micro, and macroalbuminuric groups, the multiple comparison method using ANOVA with Bonferroni correction was employed. Bivariate correlations between parameters were assessed with the Pearson or Spearman correlation coefficient for normally or nonnormally distributed variables, respectively. The distribution of ACR was normalized by logarithmic transformation before statistical analysis. Linear regression analysis was used to assess the relationship between FMD and risk factors. These relationships were fitted using least-square regression with FMD as the dependent variable. Multiple linear regression was used to analyze the associations of variables with FMD, controlling for potential confounders. For potential confounders, traditional cardiovascular risk factors, A1C, GFR and other vascular measures (IMT and PWV) were considered; therefore, age, male, UAE, BMI, A1C, smoking, SBP, eGFR, TG, HDL, IMT and PWV were entered as independent variables in the analysis. P-values 5% (two-tailed) were considered significant. All analyses were performed with the statistical software package Dr. SPSS (SPSS Japan Inc., Tokyo, Japan).
Results
Patient characteristics
Clinical characteristics of subjects according to nephropathy stages are shown in Table 1 . Subjects with micro-and macroalbuminuria were more likely to have higher proportions of insulin treatment, hypertension, dyslipidmia, retinopathy, and neuropathy, and to have higher values for age, duration of diabetes, A1C, SBP, and TG, and lower values of eGFR and HDL than those with normoalbuminuria.
Relationship between risk factors and vascular measures
Association of vascular measures with albuminuria Fig. 1 shows IMT, PWV, and FMD levels (median and interquartile ranges) in type 2 diabetic subjects with normoalbuminuria, microalbuminuria, and macroalbuminuria. Multiple comparisons revealed that IMT, PWV and FMD were associated with stages of albuminuria ( p 0.001, p 0.0001, p 0.0001, respectively). Differences between subjects with normoalbuminuria and microalbuminuria were all significant ( p 0.001, respectively), and IMT, PWV, and FMD as continuous values were significantly correlated with UAE (r 0.17, p 0.05; r 0.43, p 0.0001; r 0.36, p 0.0001, respectively). A significant difference between subjects with microlbuminuria and macroalbuminuria was observed in PWV ( p 0.002), but not in IMT and FMD.
Associations of risk factors with FMD
Age, UAE, duration of diabetes, body mass index (BMI), and SBP were inversely correlated with FMD. eGFR and HDL values were positively correlated with FMD ( Table 2) . Presence of hypertension, dyslipidemia, retinopathy, and neuropathy was associated with low FMD. We performed multivariate linear regression analysis with FMD as a dependent variable to investigate the determinants of FMD. UAE, as a continuous variable with logarithmically transformation, remained a significant determinant of FMD independent of traditional cardiovascular risk factors, A1C, eGFR and other vascular measures (IMT and PWV). 
Effect of risk factors on FMD in association with IMT levels
To investigate whether the degree of association of FMD with risk factors is different between subjects with thin and thick IMT, we compared the correlation of FMD with risk factors between subjects with IMT less (Thin) and greater (Thick) than the median. UAE was significantly associated with FMD in both Thin and Thick IMT groups. The inverse associations of FMD with IMT and PWV were significant in subjects with Thin IMT, which were abolished in Thick IMT ( Table 3 ). Significant associations of FMD with age, hypertension, SBP, dyslipidemia, TG, and HDL were observed only in subjects with Thin IMT, which were abolished in subjects with Thick IMT. FMD levels were, however, similar between subjects with Thin and Thick IMT (5.56 3.28 vs. 5.00 2.25, p 0.23).
Effect of risk factors on FMD in association with PWV levels
Correlations of FMD with risk factors between subjects with less (Low) and greater (High) than the median PWV were also investigated ( Table 3) . UAE, hypertension, SBP, retinopathy, and IMT were significantly associated with FMD only in subjects with Low PWV, but these were not associated with FMD in subjects with High PWV. FMD levels were lower in subjects with High PWV than with Low PWV (4.67 2.50 vs. 5.87 3.03, p 0.007).
Discussion
The study was performed on subjects with type 2 diabetes who were well-characterized and well-distributed according to the degree of UAE, and we con- Urinary albumin-to-creatinine ratio (mg/gcr) C firmed previous studies of ours (but different individuals) and others that showed significant increases in IMT and PWV in subjects with micro-and macroalbuminuria as compared to those with normoalbuminuria 8, [15] [16] [17] . This study of type 2 diabetes and brachial artery FMD had two main findings. First, microalbuminuria was associated with lower FMD, and UAE was a determinant of FMD independent of other cardiovascular risk factors, metabolic control, and renal function. Second, the number of risk factors that had significant correlations with FMD was higher in diabetic subjects with Thin IMT and Low PWV (mild atherosclerosis) than in those with Thick IMT and High PWV (severe atherosclerosis), respectively. The significant relationship of FMD with IMT and PWV was abolished in diabetic subjects with Thick IMT and High PWV.
FMD and IMT
FMD is a validated physiologic measure of endothelial dysfunction and IMT is an anatomic structural measure. Both reflect a condition of early atherosclerosis; however, studies of FMD in association with IMT have yielded contradictory results and have never been performed in subjects with diabetes. The majority of earlier studies showed a significant association between FMD and IMT [21] [22] [23] [24] . In these studies, subjects were young 21, 24) and healthy 21, 23) , and their numbers were small [22] [23] [24] . Recent population-based studies of middle-aged and older adults indicated no significant associations 25, 26) . Our study extended these findings to subjects with type 2 diabetes. We found that the relationship between FMD and IMT was affected by the degree of IMT in type 2 diabetes.
Dysfunctional endothelium is considered more permeable to atherogenic lipoproteins and expresses increased quantities of cytokines and growth factors 1) . These processes are likely to thicken the intima-medial layer. This is supported by Halcox et al. who showed that FMD was associated with subsequent IMT pro- gression over a 6-year prospective study 27) . In subjects whose IMT has already increased, FMD may no longer be a valid measure of early atherosclerosis.
FMD and PWV
Only a few studies have investigated the association between FMD and PWV, and no such studies have been performed in subjects with type 2 diabetes. Kobayashi et al. found a significant correlation of FMD with brachial-ankle PWV 22) . Interestingly, the significance was abolished after adjusting for age, BP, and IMT in all subjects, but remained in subjects younger than 70 yr. Kopeć et al. found a significant relationship between FMD and PWV in subjects without coronary artery stenosis, but not in subjects with coronary artery stenosis 28) . Witte et al. investigated whether FMD was affected by arterial stiffness, and found that the relationship of FMD with age and current smoking, which were used as proxies for the relation between FMD and true endothelial function, became less pronounced according to increasing arterial stiffness 29) . These studies indicated that the significant relationship between FMD and PWV was limited to individuals at a low risk of atherosclerosis, which support our finding in type 2 diabetes.
It is conceivable that stiffening and/or thickening of the arterial wall may limit the ability to dilate, even if the functional endothelium is present. Local vessel wall properties could thus affect the final ability to dilate in response to a hyperemic trigger and lead to an FMD estimate. When markers of premature atherosclerosis such as IMT and PWV are elevated, the estimated FMD may no longer be interpreted as a measure of the actual functional status of the endothelium. FMD may be a dynamic measure that reflects acute (rather than chronic) influences on endothelial function, and IMT and PWV may reflect longer lifetime exposure to risk factors. These measures would provide complementary information on the vascular status.
FMD and microalbuminuria
To our knowledge, few studies have been performed with respect to the association of brachial FMD with nephropathy stages including microalbuminuria and macroalbuminuria in type 2 diabetes, . A preliminary study showed that microalbuminuria was associated with impaired FMD only in elderly individuals (aged 70 yr) with type 2 diabetes 31) . We extended it to younger individuals (aged 60 yr) and to macroalbuminuria. In type 2 diabetes, we found that there was no significant difference in FMD between microalbuminuria and macroalbuminuria.
Microalbuminuria is a potent marker of CVD both in individuals with and without diabetes, as is the UAE value even within the normal range 12, 13) ; however, why UAE is elevated and why elevated UAE is associated with an increased risk of CVD are not fully understood. It is likely that endothelial dysfunction and chronic low-grade inflammation, presumably provoked by hyperglycemia, precedes a slight elevation of UAE, leading to "microalbuminuria" [32] [33] [34] . However, endothelial dysfunction as well as chronic lowgrade inflammation was mostly studied by serum/ plasma concentrations, such as von Willebrand factor, tissue-type plasminogen activator, soluble vascular cell adhesion molecule 1, sialic acid and C-reactive protein [32] [33] [34] , while we investigated endothelial dysfunction through measurement of brachial artery FMD. Our finding of the close association between FMD and microalbuminuria, together with the findings of the above serum markers reported previously, indicates a close linkage between endothelial dysfunction and microalbuminuria, which may be an attractive explanation for the fact that microalbuminuria is a risk marker of CVD in diabetes. Whether impaired FMD occurs even before the onset of microalbuminuria should be examined in future studies.
Study limitation
We should acknowledge a limitation that the study was cross-sectional. FMD and other values were the results after treatments in which subjects were under strictly controlled profiles for blood glucose, blood pressure, and lipids. Nevertheless, we still found the association of FMD with UAE and the interrelations of FMD with IMT and PWV. Future prospective studies in a diabetic population are needed to clarify the causal relationship and effect of intervention on vascular properties.
In conclusion, in individuals with type 2 diabetes, FMD was impaired in those with microalbuminuria. FMD was associated with IMT and PWV only when these values were rather preserved, i.e., at an early stage of atherosclerosis.
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